ADVERTISEMENT
Posted: Jul 7, 2024

Shilajit: A powerful antioxidant

On The Shelf

Shilajit supplements are sold as a superfood support for focus, memory, energy, performance, recovery, and strength. What is shilajit and does it really boost vitality?

Mickie Cathers

Read more
Posted: Jul 7, 2024

Rezdiffra for liver scarring

New Drug

In March 2024, FDA approved the first treatment option for adults with liver scarring due to fatty liver disease. Rezdiffra (resmetirom-Madrigal Pharmaceuticals) provides an option for patients with liver scarring, who previously did not have a medication option that would address liver damage.

Lauren Howell, PharmD

Read more
Posted: Jul 7, 2024

Overdose deaths involving nitazenes seem to be on the rise

Synthetic Opioids

Nitazenes, a group of powerful illicit synthetic opioids derived from 2-benzylbenzimidazole, are increasingly turning up in overdose deaths across the country.

Loren Bonner

Read more
Posted: Jun 7, 2024

Education key to stopping spread of antimicrobial-resistant ringworm

Infectious Disease

Antimicrobial-resistant ringworm made headlines last year when a New York City dermatologist notified public health officials of two patients whose ringworm did not improve with oral terbinafine. Since then, stubborn strains of the fungus, which causes itchy, scaly patches of skin, have appeared in at least 11 states, including New York.

Terri D’Arrigo

Read more
Posted: Jun 7, 2024

Trivalent flu vaccines recommended for next season

Influenza

During a March 2024 meeting, FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) made recommendations on which influenza viruses would be best to include in influenza vaccine compositions for the 2024–2025 flu season.

Olivia C. Welter, PharmD

Read more
First34568101112Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT